Welltower stock hits all-time high at 250.42 USD📈
Welltower Inc’s stock has reached a new all-time high, hitting 250.14 USD. This marks a significant milestone for the company, reflecting a robust performance over the past year. The stock has seen a remarkable 54.66% increase over the last 12 months, showcasing strong investor confidence and positive market sentiment towards Welltower’s business operations and growth prospects. This surge in stock price highlights the company’s successful strategies and its ability to capitalize on opportunities in the healthcare real estate sector.
In other recent news, Welltower Inc. reported first-quarter 2026 earnings that exceeded expectations, with earnings per share (EPS) of $1.02, surpassing the projected $0.73. The company’s revenue also outperformed forecasts, reaching $3.35 billion compared to the anticipated $3.09 billion. Additionally, Welltower is planning a bond sale in Canada to raise approximately C$750 million ($527 million) through a two-part offering, with debt maturing in five to seven years.
At the company’s annual meeting, shareholders re-elected all nine nominated directors and approved Ernst & Young LLP as the independent registered public accounting firm for 2026. However, the shareholders did not approve the compensation for the company’s named executive officers. Analyst firm Mizuho raised its price target for Welltower to $239, citing increased funds from operations estimates for 2026 and 2027. Barclays initiated coverage on Welltower with an Equalweight rating and a price target of $254, highlighting the company’s scale and sector-leading growth in Seniors Housing Operating. These developments provide investors with a comprehensive view of Welltower’s recent activities and financial performance.
